1. Home
  2. MTSI vs INM Comparison

MTSI vs INM Comparison

Compare MTSI & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MACOM Technology Solutions Holdings Inc.

MTSI

MACOM Technology Solutions Holdings Inc.

HOLD

Current Price

$174.99

Market Cap

13.3B

Sector

Technology

ML Signal

HOLD

Logo InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc.

HOLD

Current Price

$1.21

Market Cap

3.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTSI
INM
Founded
1950
1981
Country
United States
Canada
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.3B
3.7M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
MTSI
INM
Price
$174.99
$1.21
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$177.50
N/A
AVG Volume (30 Days)
1.2M
195.0K
Earning Date
02-05-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$967,258,000.00
$4,798,116.00
Revenue This Year
$18.17
N/A
Revenue Next Year
$12.69
N/A
P/E Ratio
N/A
N/A
Revenue Growth
32.58
N/A
52 Week Low
$84.00
$1.13
52 Week High
$190.95
$8.27

Technical Indicators

Market Signals
Indicator
MTSI
INM
Relative Strength Index (RSI) 52.70 39.21
Support Level $162.94 $1.20
Resistance Level $190.21 $1.36
Average True Range (ATR) 7.23 0.11
MACD -2.30 0.01
Stochastic Oscillator 41.56 9.72

Price Performance

Historical Comparison
MTSI
INM

About MTSI MACOM Technology Solutions Holdings Inc.

MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems.

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

Share on Social Networks: